PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN
Abstract Targeting mutant BRAF in patients with melanomas harboring this oncogene has been highly successful as a first-line treatment, but other mutations may affect its efficacy and alter the route of acquired resistance resulting in recurrence and poor prognosis. As an evolving strategy, melanoma...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/296a03e409584af690987eefc1e8c182 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|